|
1
|
Lukassen S, Chua RL, Trefzer T, Kahn NC,
Schneider MA, Muley T, Winter H, Meister M, Veith C, Boots AW, et
al: SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in
bronchial transient secretory cells. EMBO J.
39(e105114)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sungnak W, Huang N, Bécavin C, Berg M,
Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D,
Sampaziotis F, et al: SARS-CoV-2 entry factors are highly expressed
in nasal epithelial cells together with innate immune genes. Nat
Med. 26:681–687. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ziegler CGK, Allon SJ, Nyquist SK, Mbano
IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, et
al: SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in
human airway epithelial cells and is detected in specific cell
subsets across tissues. Cell. 181:1016–1035.e19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee JJ, Kopetz S, Vilar E, Shen JP, Chen K
and Maitra A: Relative abundance of SARS-CoV-2 entry genes in the
enterocytes of the lower gastrointestinal tract. Genes (Basel).
11(645)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zang R, Gomez Castro MF, McCune BT, Zeng
Q, Rothlauf PW, Sonnek NM, Liu Z, Brulois KF, Wang X, Greenberg HB,
et al: TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human
small intestinal enterocytes. Sci Immunol.
5(eabc3582)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lamers MM, Beumer J, van der Vaart J,
Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J,
Mykytyn AZ, Duimel HQ, et al: SARS-CoV-2 productively infects human
gut enterocytes. Science. 369:50–54. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xiao F, Tang M, Zheng X, Liu Y, Li X and
Shan H: Evidence for gastrointestinal infection of SARS-CoV-2.
Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhou J, Li C, Liu X, Chiu MC, Zhao X, Wang
D, Wei Y, Lee A, Zhang AJ, Chu H, et al: Infection of bat and human
intestinal organoids by SARS-CoV-2. Nat Med. 26:1077–1083.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni
L, Yang Y, Liu B, Wang W, Wei C, et al: The presence of SARS-CoV-2
RNA in the feces of COVID-19 patients. J Med Virol. 92:833–840.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kipkorir V, Cheruiyot I, Ngure B, Misiani
M and Munguti J: Prolonged SARS-CoV-2 RNA detection in anal/rectal
swabs and stool specimens in COVID-19 patients after negative
conversion in nasopharyngeal RT-PCR test. J Med Virol.
92:2328–2331. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong
X, Yin H, Xiao Q, Tang Y, Qu X, et al: Prolonged presence of
SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol
Hepatol. 5:434–435. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gu J, Han B and Wang J: COVID-19:
Gastrointestinal manifestations and potential fecal-oral
transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wong SH, Lui RN and Sung JJ: Covid-19 and
the digestive system. J Gastroenterol Hepatol. 35:744–748.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang L and Tu L: Implications of
gastrointestinal manifestations of COVID-19. Lancet Gastroenterol
Hepatol. 5:629–630. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Budden KF, Gellatly SL, Wood DL, Cooper
MA, Morrison M, Hugenholtz P and Hansbro PM: Emerging pathogenic
links between microbiota and the gut-lung axis. Nat Rev Microbiol.
15:55–63. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dumas A, Bernard L, Poquet Y,
Lugo-Villarino G and Neyrolles O: The role of the lung microbiota
and the gut-lung axis in respiratory infectious diseases. Cell
Microbiol. 20(e12966)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang D, Li S, Wang N, Tan HY, Zhang Z and
Feng Y: The cross-talk between gut microbiota and lungs in common
lung diseases. Front Microbiol. 11(301)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L,
Guo F, Zhang X, Luo R, Huang C, et al: Alterations of the gut
microbiota in patients with coronavirus disease 2019 or H1N1
influenza. Clin Infect Dis. 71:2669–2678. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gou W, Fu Y, Yue L, Chen GD, Cai X, Shuai
M, Xu F, Yi X, Chen H, Zhu Y, et al: Gut microbiota may underlie
the predisposition of healthy individuals to COVID-19. J Genet
Genomics. 48:792–802. 2021.
|
|
20
|
Zuo T, Liu Q, Zhang F, Lui GC, Tso EY,
Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, et al: Depicting
SARS-CoV-2 faecal viral activity in association with gut microbiota
composition in patients with COVID-19. Gut. 70:276–284.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL,
Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al: Alterations in
gut microbiota of patients with COVID-19 during time of
hospitalization. Gastroenterology. 159:944–955.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lehtoranta L, Pitkaranta A and Korpela R:
Probiotics in respiratory virus infections. Eur J Clin Microbiol
Infect Dis. 33:1289–1302. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lei WT, Shih PC, Liu SJ, Lin CY and Yeh
TL: Effect of probiotics and prebiotics on immune response to
influenza vaccination in adults: A systematic review and
meta-analysis of randomized controlled trials. Nutrients.
9(1175)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Luoto R, Ruuskanen O, Waris M, Kalliomaki
M, Salminen S and Isolauri E: Prebiotic and probiotic
supplementation prevents rhinovirus infections in preterm infants:
A randomized, placebo-controlled trial. J Allergy Clin Immunol.
133:405–413. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Turner RB, Woodfolk JA, Borish L, Steinke
JW, Patrie JT, Muehling LM, Lahtinen S and Lehtinen MJ: Effect of
probiotic on innate inflammatory response and viral shedding in
experimental rhinovirus infection-a randomised controlled trial.
Benef Microbes. 8:207–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yeh TL, Shih PC, Liu SJ, Lin CH, Liu JM,
Lei WT and Lin CY: The influence of prebiotic or probiotic
supplementation on antibody titers after influenza vaccination: A
systematic review and meta-analysis of randomized controlled
trials. Drug Des Devel Ther. 12:217–230. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Blanco-Melo D, Nilsson-Payant BE, Liu WC,
Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D,
et al: Imbalanced host response to SARS-CoV-2 drives development of
COVID-19. Cell. 181:1036–1045.e9. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cao X: COVID-19: Immunopathology and its
implications for therapy. Nat Rev Immunol. 20:269–270.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Giamarellos-Bourboulis EJ, Netea MG,
Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G,
Gkavogianni T, Adami ME, Katsaounou P, et al: Complex immune
dysregulation in COVID-19 patients with severe respiratory failure.
Cell Host Microbe. 27:992–1000.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chong HX, Yusoff NAA, Hor YY, Lew LC,
Jaafar MH, Choi SB, Yusoff MSB, Wahid N, Abdullah MFIL, Zakaria N,
et al: Lactobacillus plantarum DR7 improved upper
respiratory tract infections via enhancing immune and inflammatory
parameters: A randomized, double-blind, placebo-controlled study. J
Dairy Sci. 102:4783–4797. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rask C, Adlerberth I, Berggren A, Ahren IL
and Wold AE: Differential effect on cell-mediated immunity in human
volunteers after intake of different lactobacilli. Clin Exp
Immunol. 172:321–332. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kechaou N, Chain F, Gratadoux JJ, Blugeon
S, Bertho N, Chevalier C, Le Goffic R, Courau S, Molimard P, Chatel
JM, et al: Identification of one novel candidate probiotic
Lactobacillus plantarum strain active against influenza
virus infection in mice by a large-scale screening. Appl Environ
Microbiol. 79:1491–1499. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Park MK, Ngo V, Kwon YM, Lee YT, Yoo S,
Cho YH, Hong SM, Hwang HS, Ko EJ, Jung YJ, et al: Lactobacillus
plantarum DK119 as a probiotic confers protection against
influenza virus by modulating innate immunity. PLoS One.
8(e75368)2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kawashima T, Hayashi K, Kosaka A,
Kawashima M, Igarashi T, Tsutsui H, Tsuji NM, Nishimura I, Hayashi
T and Obata A: Lactobacillus plantarum strain YU from
fermented foods activates Th1 and protective immune responses. Int
Immunopharmacol. 11:2017–2024. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kikuchi Y, Kunitoh-Asari A, Hayakawa K,
Imai S, Kasuya K, Abe K, Adachi Y, Fukudome S, Takahashi Y and
Hachimura S: Oral administration of Lactobacillus plantarum
strain AYA enhances IgA secretion and provides survival protection
against influenza virus infection in mice. PLoS One.
9(e86416)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kim DH, Chung WC, Chun SH, Han JH, Song MJ
and Lee KW: Enhancing the natural killer cell activity and
anti-influenza effect of heat-treated Lactobacillus
plantarum nF1-fortified yogurt in mice. J Dairy Sci.
101:10675–10684. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Maeda N, Nakamura R, Hirose Y, Murosaki S,
Yamamoto Y, Kase T and Yoshikai Y: Oral administration of
heat-killed Lactobacillus plantarum L-137 enhances
protection against influenza virus infection by stimulation of type
I interferon production in mice. Int Immunopharmacol. 9:1122–1125.
2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Park S, Kim JI, Bae JY, Yoo K, Kim H, Kim
IH, Park MS and Lee I: Effects of heat-killed Lactobacillus
plantarum against influenza viruses in mice. J Microbiol.
56:145–149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Takeda S, Takeshita M, Kikuchi Y, Dashnyam
B, Kawahara S, Yoshida H, Watanabe W, Muguruma M and Kurokawa M:
Efficacy of oral administration of heat-killed probiotics from
Mongolian dairy products against influenza infection in mice:
Alleviation of influenza infection by its immunomodulatory activity
through intestinal immunity. Int Immunopharmacol. 11:1976–1983.
2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kawahara T, Takahashi T, Oishi K, Tanaka
H, Masuda M, Takahashi S, Takano M, Kawakami T, Fukushima K,
Kanazawa H and Suzuki T: Consecutive oral administration of
Bifidobacterium longum MM-2 improves the defense system
against influenza virus infection by enhancing natural killer cell
activity in a murine model. Microbiol Immunol. 59:1–12.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Namba K, Hatano M, Yaeshima T, Takase M
and Suzuki K: Effects of Bifidobacterium longum BB536
administration on influenza infection, influenza vaccine antibody
titer, and cell-mediated immunity in the elderly. Biosci Biotechnol
Biochem. 74:939–945. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sugimura T, Takahashi H, Jounai K, Ohshio
K, Kanayama M, Tazumi K, Tanihata Y, Miura Y, Fujiwara D and
Yamamoto N: Effects of oral intake of plasmacytoid dendritic
cells-stimulative lactic acid bacterial strain on pathogenesis of
influenza-like illness and immunological response to influenza
virus. Br J Nutr. 114:727–733. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shi HY, Zhu X, Li WL, Mak JWY, Wong SH,
Zhu ST, Guo SL, Chan FKL, Zhang ST and Ng SC: Modulation of gut
microbiota protects against viral respiratory tract infections: A
systematic review of animal and clinical studies. Eur J Nutr: Apr
14, 2021 (Epub ahead of print).
|
|
44
|
Wang F, Pan B, Xu S, Xu Z, Zhang T, Zhang
Q, Bao Y, Wang Y, Zhang J, Xu C and Xue X: A meta-analysis reveals
the effectiveness of probiotics and prebiotics against respiratory
viral infection. Biosci Rep. 41(BSR20203638)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wei PF (ed): Diagnosis and Treatment
Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin
Med J (Engl). 133:1087–1095. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cao P, Wu S, Wu T, Deng Y, Zhang Q, Wang K
and Zhang Y: The important role of polysaccharides from a
traditional Chinese medicine-Lung cleansing and detoxifying
decoction against the COVID-19 pandemic. Carbohydr Polym.
240(116346)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Shi N, Liu B, Liang N, Ma Y, Ge Y, Yi H,
Wo H, Gu H, Kuang Y, Tang S, et al: Association between early
treatment with Qingfei Paidu decoction and favorable clinical
outcomes in patients with COVID-19: A retrospective multicenter
cohort study. Pharmacol Res. 161(105290)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zhao ZH, Zhou Y, Li WH, Huang QS, Tang ZH
and Li H: Analysis of traditional Chinese medicine diagnosis and
treatment strategies for COVID-19 based on ‘The Diagnosis and
Treatment Program for Coronavirus Disease-2019’ from Chinese
Authority. Am J Chin Med. 48:1035–1049. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zhong LLD, Lam WC, Yang W, Chan KW, Sze
SCW, Miao J, Yung KKL, Bian Z and Wong VT: Potential targets for
treatment of coronavirus disease 2019 (COVID-19): A review of
Qing-Fei-Pai-Du-Tang and its major herbs. Am J Chin Med.
48:1051–1071. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Xin S, Cheng X, Zhu B, Liao X, Yang F,
Song L, Shi Y, Guan X, Su R, Wang J, et al: Clinical retrospective
study on the efficacy of Qingfei Paidu decoction combined with
Western medicine for COVID-19 treatment. Biomed Pharmacother.
129(110500)2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kageyama Y, Aida K, Kawauchi K, Morimoto
M, Ebisui T, Akiyama T and Nakamura T: Qingfei Paidu decoction, a
Chinese herbal medicine against COVID-19, elevates the blood levels
of pro-inflammatory cytokines: An open-label, single-arm pilot
study. World Acad Sci J. 3(25)2021.
|
|
52
|
Popkin BM, Du S, Green WD, Beck MA,
Algaith T, Herbst CH, Alsukait RF, Alluhidan M, Alazemi N and
Shekar M: Individuals with obesity and COVID-19: A global
perspective on the epidemiology and biological relationships. Obes
Rev. 21(e13128)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kompaniyets L, Goodman AB, Belay B,
Freedman DS, Sucosky MS, Lange SJ, Gundlapalli AV, Boehmer TK and
Blanck HM: Body mass index and risk for COVID-19-related
hospitalization, intensive care unit admission, invasive mechanical
ventilation, and Death-United States, march-december 2020. MMWR
Morb Mortal Wkly Rep. 70:355–361. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Elshazli RM, Toraih EA, Elgaml A,
El-Mowafy M, El-Mesery M, Amin MN, Hussein MH, Killackey MT, Fawzy
MS and Kandil E: Diagnostic and prognostic value of hematological
and immunological markers in COVID-19 infection: A meta-analysis of
6320 patients. PLoS One. 15(e0238160)2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Mesas AE, Cavero-Redondo I, Álvarez-Bueno
C, Sarriá Cabrera MA, Maffei de Andrade S, Sequí-Dominguez I and
Martínez-Vizcaíno V: Predictors of in-hospital COVID-19 mortality:
A comprehensive systematic review and meta-analysis exploring
differences by age, sex and health conditions. PLoS One.
15(e0241742)2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z,
Jia X, Wu M, Shi B, Xu S, et al: Viral and host factors related to
the clinical outcome of COVID-19. Nature. 583:437–440.
2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Okumura A, Watanabe T, Hayashi K and
Yoshida H: Oral administration of distribution-processed
Lactobacillus plantarum strain SNK12 protects against
influenza virus infection. Jpn Pharmacol Ther. 47:1607–1612.
2019.
|
|
58
|
Watanabe T, Hayashi K, Kan T, Ohwaki M and
Kawahara T: Anti-influenza virus effects of Enterococcus faecalis
KH2 and Lactobacillus plantarum SNK12 RNA. Biosci Microbiota
Food Health. 40:43–49. 2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Xiao JZ, Kondo S, Yanagisawa N, Miyaji K,
Enomoto K, Sakoda T, Iwatsuki K and Enomoto T: Clinical efficacy of
probiotic Bifidobacterium longum for the treatment of
symptoms of Japanese cedar pollen allergy in subjects evaluated in
an environmental exposure unit. Allergol Int. 56:67–75.
2007.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Xiao JZ, Kondo S, Yanagisawa N, Takahashi
N, Odamaki T, Iwabuchi N, Iwatsuki K, Kokubo S, Togashi H, Enomoto
K and Enomoto T: Effect of probiotic Bifidobacterium longum
BB536 [corrected] in relieving clinical symptoms and modulating
plasma cytokine levels of Japanese cedar pollinosis during the
pollen season. A randomized double-blind, placebo-controlled trial.
J Investig Allergol Clin Immunol. 16:86–93. 2006.PubMed/NCBI
|
|
61
|
Iwabuchi N, Xiao JZ, Yaeshima T and
Iwatsuki K: Oral administration of Bifidobacterium longum
ameliorates influenza virus infection in mice. Biol Pharm Bull.
34:1352–1355. 2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Lau AS, Yanagisawa N, Hor YY, Lew LC, Ong
JS, Chuah LO, Lee YY, Choi SB, Rashid F, Wahid N, et al:
Bifidobacterium longum BB536 alleviated upper respiratory
illnesses and modulated gut microbiota profiles in Malaysian
pre-school children. Benef Microbes. 9:61–70. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Odamaki T, Sugahara H, Yonezawa S,
Yaeshima T, Iwatsuki K, Tanabe S, Tominaga T, Togashi H, Benno Y
and Xiao JZ: Effect of the oral intake of yogurt containing
Bifidobacterium longum BB536 on the cell numbers of
enterotoxigenic Bacteroides fragilis in microbiota. Anaerobe.
18:14–18. 2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Odamaki T, Xiao JZ, Iwabuchi N, Sakamoto
M, Takahashi N, Kondo S, Miyaji K, Iwatsuki K, Togashi H, Enomoto T
and Benno Y: Influence of Bifidobacterium longum BB536
intake on faecal microbiota in individuals with Japanese cedar
pollinosis during the pollen season. J Med Microbiol. 56:1301–1308.
2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Holvoet S, Zuercher AW, Julien-Javaux F,
Perrot M and Mercenier A: Characterization of candidate
anti-allergic probiotic strains in a model of th2-skewed human
peripheral blood mononuclear cells. Int Arch Allergy Immunol.
161:142–154. 2013.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Medina M, Izquierdo E, Ennahar S and Sanz
Y: Differential immunomodulatory properties of Bifidobacterium
logum strains: Relevance to probiotic selection and clinical
applications. Clin Exp Immunol. 150:531–538. 2007.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Niers LE, Timmerman HM, Rijkers GT, van
Bleek GM, van Uden NO, Knol EF, Kapsenberg ML, Kimpen JL and
Hoekstra MO: Identification of strong interleukin-10 inducing
lactic acid bacteria which down-regulate T helper type 2 cytokines.
Clin Exp Allergy. 35:1481–1489. 2005.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Hoffmann G, Wirleitner B and Fuchs D:
Potential role of immune system activation-associated production of
neopterin derivatives in humans. Inflamm Res. 52:313–321.
2003.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Gieseg SP, Baxter-Parker G and Lindsay A:
Neopterin, inflammation, and Oxidative Stress: What could we be
missing? Antioxidants (Basel). 7(80)2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Hausen A, Fuchs D, König K and Wachter H:
Determination of neopterine in human urine by reversed-phase
high-performance liquid chromatography. J Chromatogr. 227:61–70.
1982.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Gleiss A, Sanchez-Cabo F, Perco P, Tong D
and Heinze G: Adaptive trimmed t-statistics for identifying
predominantly high expression in a microarray experiment. Stat Med.
30:52–61. 2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Krzywinski M and Altman N: Visualizing
samples with box plots. Nat Methods. 11:119–120. 2014.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Domthong U, Parikh CR, Kimmel PL and
Chinchilli VM: Assessment, Serial Evaluation, Subsequent Sequelae
of Acute Kidney Injury Consortium. Assessing the agreement of
biomarker data in the presence of left-censoring. BMC Nephrol.
15(144)2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Yu X, Lakerveld AJ, Imholz S, Hendriks M,
Ten Brink SCA, Mulder HL, de Haan K, Schepp RM, Luytjes W, de Jong
MD, et al: Antibody and local cytokine response to respiratory
syncytial virus infection in community-dwelling older adults.
mSphere. 5:e00577–20. 2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Faul F, Erdfelder E, Lang AG and Buchner
A: G*Power 3: A flexible statistical power analysis program for the
social, behavioral, and biomedical sciences. Behav Res Methods.
39:175–191. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Waggoner SN, Reighard SD, Gyurova IE,
Cranert SA, Mahl SE, Karmele EP, McNally JP, Moran MT, Brooks TR,
Yaqoob F, et al: Roles of natural killer cells in antiviral
immunity. Curr Opin Virol. 16:15–23. 2016.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Björkström NK, Strunz B and Ljunggren HG:
Natural killer cells in antiviral immunity. Nat Rev Immunol: Jun
11, 2021 (Epub ahead of print).
|
|
79
|
Berggren A, Lazou Ahren I, Larsson N and
Onning G: Randomised, double-blind and placebo-controlled study
using new probiotic lactobacilli for strengthening the body immune
defence against viral infections. Eur J Nutr. 50:203–210.
2011.PubMed/NCBI View Article : Google Scholar
|
|
80
|
International Home Medical (IHM):
Plant-origin nano-particled (Pro)-Biogenics immunophilus SNK.
Plant-origin nano-sized lactic acid bacterium SNK®. IHM
Inc., Tolyo, 2021. https://www.ihmg.jp/nyusan_snk_en/. Accessed October
14, 2021.
|
|
81
|
Chen N, Xia P, Li S, Zhang T, Wang TT and
Zhu J: RNA sensors of the innate immune system and their detection
of pathogens. IUBMB Life. 69:297–304. 2017.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Moreno-Eutimio MA, Lopez-Macias C and
Pastelin-Palacios R: Bioinformatic analysis and identification of
single-stranded RNA sequences recognized by TLR7/8 in the
SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect.
22:226–229. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Slaats J, Ten Oever J, van de Veerdonk FL
and Netea MG: IL-1β/IL-6/CRP and IL-18/ferritin: Distinct
inflammatory programs in infections. PLoS Pathog.
12(e1005973)2016.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Mick E, Kamm J, Pisco AO, Ratnasiri K,
Babik JM, Castañeda G, DeRisi JL, Detweiler AM, Hao SL, Kangelaris
KN, et al: Upper airway gene expression reveals suppressed immune
responses to SARS-CoV-2 compared with other respiratory viruses.
Nat Commun. 11(5854)2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
van der Made CI, Simons A,
Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van
Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M, et al:
Presence of genetic variants among young men with severe COVID-19.
JAMA. 324:663–673. 2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Liu C, Martins AJ, Lau WW, Rachmaninoff N,
Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, et
al: Time-resolved systems immunology reveals a late juncture linked
to fatal COVID-19. Cell. 184:1836–1857.e22. 2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Sahoo D, Katkar GD, Khandelwal S,
Behroozikhah M, Claire A, Castillo V, Tindle C, Fuller M, Taheri S,
Rogers TF, et al: AI-guided discovery of the invariant host
response to viral pandemics. EBioMedicine.
68(103390)2021.PubMed/NCBI View Article : Google Scholar
|
